Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric oxide nasal spray for COVID-19 prevention
NCT05109611Phase 3Terminated
- Sponsor
- SaNOtize
- Start
- Nov 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 2
01
Overview
A Phase 3 trial of Nitric oxide patch (Fundación Cardiovascular de Colombia) in coronavirus disease 2019 (COVID-19), sponsored by SaNOtize. Started Nov 2021; status: terminated.
02
Drugs
Nitric oxide patch (Fundación Cardiovascular de Colombia)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05109611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05109611.